Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs NUTRAPLUS PR - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. NUTRAPLUS PR MARKSANS PHARMA./
NUTRAPLUS PR
 
P/E (TTM) x 21.5 -0.1 - View Chart
P/BV x 3.9 0.3 1,188.1% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 MARKSANS PHARMA.   NUTRAPLUS PR
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
NUTRAPLUS PR
Mar-20
MARKSANS PHARMA./
NUTRAPLUS PR
5-Yr Chart
Click to enlarge
High Rs7422 340.0%   
Low Rs395 722.0%   
Sales per share (Unadj.) Rs40.925.6 159.5%  
Earnings per share (Unadj.) Rs5.9-14.0 -41.7%  
Cash flow per share (Unadj.) Rs7.0-12.7 -55.3%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.56.3 607.4%  
Shares outstanding (eoy) m453.1634.09 1,329.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.40.5 260.2%   
Avg P/E ratio x9.7-1.0 -994.7%  
P/CF ratio (eoy) x8.1-1.1 -750.3%  
Price / Book Value ratio x1.52.1 68.3%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,631464 5,518.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,39473 3,261.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,521873 2,120.6%  
Other income Rs m5931 41,477.6%   
Total revenues Rs m19,115875 2,184.9%   
Gross profit Rs m3,393-358 -946.8%  
Depreciation Rs m51947 1,103.0%   
Interest Rs m9174 122.8%   
Profit before tax Rs m3,377-478 -706.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7230-   
Profit after tax Rs m2,653-478 -554.8%  
Gross profit margin %18.3-41.0 -44.7%  
Effective tax rate %21.40-   
Net profit margin %14.3-54.8 -26.2%  
BALANCE SHEET DATA
Current assets Rs m16,997178 9,551.9%   
Current liabilities Rs m3,654890 410.6%   
Net working cap to sales %72.0-81.5 -88.4%  
Current ratio x4.70.2 2,326.4%  
Inventory Days Days61 882.2%  
Debtors Days Days8211,562,625 0.0%  
Net fixed assets Rs m5,246939 558.9%   
Share capital Rs m453170 265.8%   
"Free" reserves Rs m16,99846 37,203.9%   
Net worth Rs m17,452216 8,074.2%   
Long term debt Rs m02 0.0%   
Total assets Rs m22,2421,117 1,992.1%  
Interest coverage x38.0-5.4 -699.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 106.5%   
Return on assets %12.3-36.2 -34.1%  
Return on equity %15.2-221.3 -6.9%  
Return on capital %19.9-185.1 -10.7%  
Exports to sales %01.3 0.0%   
Imports to sales %7.30.7 1,062.2%   
Exports (fob) Rs mNA11 0.0%   
Imports (cif) Rs m1,3486 22,510.9%   
Fx inflow Rs m6,49111 57,650.4%   
Fx outflow Rs m1,3486 22,510.9%   
Net fx Rs m5,1435 97,590.9%   
CASH FLOW
From Operations Rs m2,37491 2,617.6%  
From Investments Rs m-2,592-27 9,650.5%  
From Financial Activity Rs m1,978-76 -2,614.4%  
Net Cashflow Rs m1,760-12 -14,880.1%  

Share Holding

Indian Promoters % 43.9 40.1 109.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 0.0 67,733.3%  
FIIs % 15.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 59.9 93.7%  
Shareholders   237,377 7,943 2,988.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs NUTRAPLUS PR

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs NUTRAPLUS PR Share Price Performance

Period MARKSANS PHARMA. NUTRAPLUS PR S&P BSE HEALTHCARE
1-Day 0.46% 5.00% 1.18%
1-Month -0.72% 9.95% -0.75%
1-Year 109.61% -60.67% 61.82%
3-Year CAGR 45.11% -52.30% 18.16%
5-Year CAGR 43.62% -40.89% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the NUTRAPLUS PR share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of NUTRAPLUS PR the stake stands at 40.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of NUTRAPLUS PR.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

NUTRAPLUS PR paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of NUTRAPLUS PR.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.